Charles River Laboratories International Inc (FRA:RV6)
€ 174.9 -0.95 (-0.54%) Market Cap: 9.09 Bil Enterprise Value: 11.58 Bil PE Ratio: 23.14 PB Ratio: 2.51 GF Score: 85/100

Charles River Laboratories International Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 02:10PM GMT
Release Date Price: €185.05 (-0.62%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

All right. Thanks, everyone, for joining us. My name is Tejas Savant and I'm the Life Science Tools and Diagnostics Analyst at Morgan Stanley. Before we begin, I'd like to remind our listeners that important disclosure information can be found at morganstanley.com/research disclosures. So it's my pleasure today to host Charles River, and speaking on behalf of the company, we have Chairman, President and CEO, Jim Foster. Thank you for joining us today, Jim.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Maybe to just set the stage, let's start with the biopharma funding environment. You've called out sort of stable to improving trends here in the second quarter. It's something we've heard from other life science companies as well over the last couple of days. But then on the other hand, you've also talked about I guess, an inevitable normalization following a pretty unique multiyear period of R&D budget strength. Help us think

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot